Omada Health to Prescribe GLP-1 and Obesity Drugs, Expands Virtual Weight Management Program
Prime Highlight: Omada Health will begin prescribing GLP-1s and other obesity medications as part of
Emerging Weight-Loss Drugs Focus on Muscle Preservation Amid Growing Market
Prime Highlights: A dozen drugmakers are developing new weight-loss treatments that prioritize muscle mass preservation
Leveraging AI to Accelerate the Discovery of New Tuberculosis Drug Targets
Prime Highlights: Tuberculosis (TB) continues to affect millions globally, with rising concerns over drug-resistant strains.
Merck KGaA Engages in Advanced Acquisition Talks with SpringWorks Therapeutics
Prime Highlights: Germany’s Merck KGaA is negotiating to acquire U.S. biotech firm SpringWorks Therapeutics, specializing
Eli Lilly to Release Early Data on Retatrutide Next-Generation Weight Loss Drug in 2025
Prime Highlights: Eli Lilly plans to release late-stage trial data for Retatrutide in 2025, ahead
Life Science Witnesses Digital Transformation in DIA Europe
Key highlights: Spotlight on emerging Technologies AI-driven Innovation with Dolffia Industry Whitepaper Release NTT DATA
Beckman Coulter Life Sciences Expands Leukemia and Lymphoma Testing in Africa
Key Highlights: • $2.5 Million Grant to Expand Testing in Kenya • Significant Improvement in
Bruker Launches LUMOS™ II ILIM for Enhanced Infrared Imaging in Pharma and Life Science Research
Key Highlights: High Performance Infrared Imaging AI-powered Data Evaluation and Multi-modal imaging Versatile and customizable
UnitedHealthcare Appoints Tim Noel as CEO Amid Industry Challenges
Prime Highlights: Noel, who has been with UnitedHealthcare since 2007, previously led the Medicare and
Novo Nordisk Shares Surge Following Promising Trial Results for Weight-Loss Drug
Prime Highlights: The company’s stock rose significantly after promising results from an early-stage trial of
M42 Strengthens Position as Middle East’s Largest Healthcare Firm with New Restructure and Expansion Plans
Prime Highlights: M42, the Middle East’s largest healthcare company, introduces a new operational structure to
FDA Expands Approval for J&J’s Spravato as Standalone Depression Treatment
Prime Highlights: The FDA has approved Johnson & Johnson’s Spravato (esketamine) nasal spray for standalone